These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14986159)

  • 1. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.
    Colodner R; Rock W; Chazan B; Keller N; Guy N; Sakran W; Raz R
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):163-7. PubMed ID: 14986159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children.
    Kizilca O; Siraneci R; Yilmaz A; Hatipoglu N; Ozturk E; Kiyak A; Ozkok D
    Pediatr Int; 2012 Dec; 54(6):858-62. PubMed ID: 22882781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
    Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
    Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility.
    Mendelson G; Hait V; Ben-Israel J; Gronich D; Granot E; Raz R
    Eur J Clin Microbiol Infect Dis; 2005 Jan; 24(1):17-22. PubMed ID: 15660255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
    Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
    PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Yilmaz E; Akalin H; Ozbey S; Kordan Y; Sinirtaş M; Gürcüoglu E; Ozakin C; Heper Y; Mistik R; Helvaci S
    J Chemother; 2008 Oct; 20(5):581-5. PubMed ID: 19028620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
    Huang Y; Zhuang S; Du M
    Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase
    Koksal E; Tulek N; Sonmezer MC; Temocin F; Bulut C; Hatipoglu C; Erdinc FS; Ertem G
    Investig Clin Urol; 2019 Jan; 60(1):46-53. PubMed ID: 30637361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.